INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo SABAX MIDAZOLAM INJECTION 5 mg/5 mL
SABAX MIDAZOLAM INJECTION 15 mg/3 mL
SABAX MIDAZOLAM INJECTION 50 mg/10 mL

For full prescribing information refer to the package insert approved by the medicines regulatory authority. This document has not yet been made available to us.

SCHEDULING STATUS:
S5

PROPRIETARY NAME
(and dosage form):

SABAX MIDAZOLAM INJECTION 5 mg/5 mL
SABAX MIDAZOLAM INJECTION 15 mg/3 mL
SABAX MIDAZOLAM INJECTION 50 mg/10 mL

COMPOSITION:
SABAX MIDAZOLAM INJECTION 5 mg/5 mL        each 5,0 mL solution contains:
midazolam 5,0 mg
SABAX MIDAZOLAM INJECTION 15 mg/3 mL        each 3,0 mL solution contains:midazolam 15,0 mg
SABAX MIDAZOLAM INJECTION 50 mg/10 mL        each 10,0 mL solution contains: midazolam 50,0 mg

ATC CLASSIFICATION:
N05CD08

PRESENTATION/PACK SIZE:
no data

REGISTRATION NUMBER:
A40/2.2/0569 SABAX MIDAZOLAM INJECTION 5 mg/5 mL
A40/202/0570 SABAX MIDAZOLAM INJECTION 15 mg/3 mL
A40/2.2/0571 SABAX MIDAZOLAM INJECTION 50 mg/10 mL

APPLICANT:
ADCOCK INGRAM CRITICAL CARE (PTY) LTD

MANUFACTURER:
no data

AVAILABILITY:
no data

DATE OF REGISTRATION:
no data

SOURCE:
REGISTRAR OF MEDICINES
12.43 Notification of Registration Oct08 v1.doc        Nov 2008

Date posted:
August 2014

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2014